Avadel Pharmaceuticals Enters into Royalty Agreement with RTW Investments for up to $75 Million
Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, announced its entry into a royalty agreement with RTW Investments, LP and…
Read More...
Read More...
